---
title: "Charming Medical Appoints Mei Cai as Independent Director and Audit Chair After Board Resignation"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285355977.md"
description: "Charming Medical Limited appointed Mei Cai as an independent director and audit chair following the resignation of Matthew Mo Kan Tsui. Tsui's departure was accepted on May 2, 2026, with no disagreements noted. Cai, a veteran finance executive, brings over 20 years of experience in accounting and SEC reporting, enhancing the company's financial governance. Her appointment, with an annual compensation of $50,000, aims to strengthen board independence and reassure investors about oversight continuity. Charming Medical, based in Hong Kong and listed in the U.S., focuses on compliance with U.S. listing standards."
datetime: "2026-05-06T10:28:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285355977.md)
  - [en](https://longbridge.com/en/news/285355977.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285355977.md)
---

# Charming Medical Appoints Mei Cai as Independent Director and Audit Chair After Board Resignation

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Charming Medical Limited Class A ( (MCTA) ) just unveiled an update.

On April 27, 2026, independent director Matthew Mo Kan Tsui resigned from Charming Medical Limited’s board to pursue other business commitments, with the board formally accepting his departure on May 2, 2026 and clarifying that it did not arise from any disagreement over the company’s operations or policies. On May 2, 2026, the board and its key committees appointed veteran finance executive Mei Cai as an independent director, naming her chair of the audit committee and member of the compensation and nominating committees, bolstering the company’s U.S. capital markets and financial oversight expertise by designating her as an audit committee financial expert under SEC and Nasdaq rules.

Cai’s appointment, with annual compensation of US$50,000, signals Charming Medical’s focus on strengthening board independence and financial governance following Tsui’s exit, which may reassure investors about continuity in oversight. Her two decades of experience in accounting, SEC reporting and Nasdaq listings, along with current and past directorships at other U.S.-listed companies, position the company to navigate regulatory and capital markets demands more effectively while maintaining compliance with audit committee independence and qualification requirements.

**More about Charming Medical Limited Class A**

Charming Medical Limited is a Hong Kong-based company incorporated in the British Virgin Islands and listed in the U.S. as a foreign private issuer. It operates within the healthcare and medical sector, although this filing centers on corporate governance rather than product or market updates, underscoring its ongoing alignment with U.S. listing and compliance standards.

**Technical Sentiment Signal:** Strong Sell

**Current Market Cap:** $504.3M

For a thorough assessment of MCTA stock, go to TipRanks’ Stock Analysis page.

### Related Stocks

- [MCTA.US](https://longbridge.com/en/quote/MCTA.US.md)

## Related News & Research

- [ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026 | ONWRY Stock News](https://longbridge.com/en/news/286858298.md)
- [ENvue Medical delays quarterly SEC filing](https://longbridge.com/en/news/286623972.md)
- [03:00 ETGreenberg Traurig's Capital Markets Practice Recognized Across Five Winning Deals of the Year at Islamic Finance News Awards 2025](https://longbridge.com/en/news/287020144.md)
- [Kornit Digital joins Craig-Hallum institutional investor conference, hosts one-on-one meetings](https://longbridge.com/en/news/287060555.md)
- [Redsense Medical AGM adopted proposal to carry forward SEK 32.04 million](https://longbridge.com/en/news/287092867.md)